India-UK Partnership on Antimicrobial Resistance Management

This briefing paper discusses the partnership between India and the UK in addressing antimicrobial resistance (AMR) stemming from pharmaceutical manufacturing waste. It outlines the global health threat posed by AMR, emphasizing the need for research to develop strategies that mitigate environmental contamination. The document highlights the significant role of India in the global pharmaceutical supply chain, particularly in the production of formulated drugs, and the environmental risks associated with antibiotic manufacturing. It details the policies and international frameworks established to combat AMR, including the World Health Organization's Global Action Plan, which aims to improve awareness, strengthen surveillance, and optimize antimicrobial use. The paper also presents the specific actions taken by India to align its National Action Plan with global efforts, focusing on monitoring antibiotic residues and enhancing environmental risk assessments. Furthermore, it discusses the collaborative efforts between the UK and India to promote responsible antimicrobial manufacturing practices and environmental stewardship.